Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 25.4.2023Takeda Manufacturing Austria AG (TKM-5)97248KIOVIG 100 mg/ml infúzny intravenózny roztok (sol inf 1x100 ml/10 g (liek.inj.skl.))26.4.2023R
 25.4.2023Takeda Manufacturing Austria AG (TKM-5)97250KIOVIG 100 mg/ml infúzny intravenózny roztok (sol inf 1x200 ml/20 g (liek.inj.skl.))26.4.2023R
 25.4.2023Bristol-Myers Squibb Pharma EEIG (BMS-IE)5007DReblozyl 75 mg prášok na injekčný roztok (plv ino 1x75 mg (liek.inj.skl.))19.4.2023U
 25.4.2023Olikla s.r.o. (OLK)2375DLatanoprost/timolol Olikla 0,05 mg/ml + 5 mg/ml očné roztokové kvapky (int opo 1x2,5 ml (fľ.LDPE))4.4.2023R
 25.4.2023Chiesi Pharmaceuticals GmbH (CHS-AT)84575Otobacid N (int ots 1x5 ml (liek.skl.))25.4.2023R
 25.4.2023Mundipharma Gesellschaft m.b.H. (MUP-A-2)92278PALLADONE-SR capsules 2 mg (cps pld 60x2 mg (blis.PVC/PVDC/Al))2.5.2023O
 24.4.2023IBSA Slovakia s.r.o. (IBS-SK-1)7924DGonasi Kit (plv iol 1x5000 IU+1x1 ml (liek.inj.skl.+striek.inj.skl.+ihly))1.1.2023U
 24.4.2023Neuraxpharm Bohemia s.r.o. (NUA)1045DDuoxona 10 mg/5 mg tablety s predĺženým uvoľňovaním (tbl plg 60x10 mg/5 mg (blis.Al/PVC/PE/PVDC))1.5.2023U
 24.4.2023Neuraxpharm Bohemia s.r.o. (NUA)1059DDuoxona 20 mg/10 mg tablety s predĺženým uvoľňovaním (tbl plg 60x20 mg/10 mg (blis.Al/PVC/PE/PVDC))1.5.2023U
 24.4.2023Neuraxpharm Bohemia s.r.o. (NUA)1087DDuoxona 40 mg/20 mg tablety s predĺženým uvoľňovaním (tbl plg 60x40 mg/20 mg (blis.Al/PVC/PE/PVDC))1.5.2023U
 24.4.2023Takeda Manufacturing Austria AG (TKM-5)97248KIOVIG 100 mg/ml infúzny intravenózny roztok (sol inf 1x100 ml/10 g (liek.inj.skl.))17.4.2023O
 24.4.2023Takeda Manufacturing Austria AG (TKM-5)97250KIOVIG 100 mg/ml infúzny intravenózny roztok (sol inf 1x200 ml/20 g (liek.inj.skl.))17.4.2023O
 24.4.2023Takeda Manufacturing Austria AG (TKM-5)20049KIOVIG 100 mg/ml infúzny intravenózny roztok (sol inf 1x300 ml/30 g (liek.inj.skl.))17.4.2023O
 22.4.2023Gedeon Richter Plc. (GDN)0256BBemfola 300 IU/0,50 ml injekčný roztok v naplnenom pere (sol inj 1x0,50 ml/300 IU (náplň skl.v napl.pere + 1 ihla))22.4.2023R
 21.4.2023Glenmark Pharmaceuticals s.r.o. (GLM-CZ)7137BEzetimibe Glenmark 10 mg tablety (tbl 30x10 mg (blis.PVC/Aclar/Al))31.8.2023Z

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)